CZOOF |
Cazoo Group Ltd |
Class A Ordinary Shares, par value $0.20 per share |
43.8% |
$42.9K |
|
2.14M |
|
VIKING GLOBAL INVESTORS LP |
Feb 1, 2024 |
BBIO |
BridgeBio Pharma, Inc. |
Common Stock, par value $0.001 per share |
11.7% |
$719M |
|
22.1M |
|
VIKING GLOBAL INVESTORS LP |
Jan 31, 2025 |
APG |
APi Group Corp |
Common Stock, $0.0001 par value per share |
7.8% |
$825M |
|
21.5M |
|
VIKING GLOBAL INVESTORS LP |
Dec 31, 2024 |
SION |
Sionna Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
6.7% |
$50.5M |
|
2.95M |
|
VIKING GLOBAL INVESTORS LP |
Feb 10, 2025 |
NAMS |
NewAmsterdam Pharma Co N.V. |
Ordinary Shares, nominal value EUR0.12 per share |
6.5% |
$163M |
|
6.98M |
|
VIKING GLOBAL INVESTORS LP |
Dec 31, 2024 |
RRX |
REGAL REXNORD CORP |
Common Stock, $0.01 par value per share |
5.3% |
$421M |
|
3.55M |
|
VIKING GLOBAL INVESTORS LP |
Apr 11, 2025 |
LBPH |
Longboard Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
0% |
$0 |
|
0 |
|
VIKING GLOBAL INVESTORS LP |
Dec 31, 2024 |